Non-clinical safety of monoclonal antibodies for human use

被引：0
|
作者：
Suzuki-Nishimura, Tamiko [1 ]
机构：
[1] Pharmaceut & Med Devices Agcy, Tokyo 1000013, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：148P / 148P
页数：1
相关论文
共 50 条
  • [41] Use of minipigs in non-clinical juvenile toxicology studies
    Makin, Andrew
    Skytte, Christina
    Grand, Nanna
    TOXICOLOGY, 2010, 278 (03) : 373 - 374
  • [42] The use of the Decision Regret Scale in non-clinical contexts
    Diotaiuti, Pierluigi
    Valente, Giuseppe
    Mancone, Stefania
    Grambone, Angela
    Chirico, Andrea
    Lucidi, Fabio
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [43] Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies
    Muller, P. Y.
    Brennan, F. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) : 247 - 258
  • [44] A non-clinical comparative study of IL-23 antibodies in psoriasis
    Zhou, Li
    Wang, Yibing
    Wan, Qi
    Wu, Fei
    Barbon, Jeffrey
    Dunstan, Robert
    Gauld, Stephen
    Konrad, Mark
    Leys, Laura
    McCarthy, Richard
    Namovic, Marian
    Nelson, Christine
    Overmeyer, Gary
    Perron, Denise
    Su, Zhi
    Wang, Leyu
    Westmoreland, Susan
    Zhang, Jun
    Zhu, Rui
    Veldman, Geertruida
    MABS, 2021, 13 (01)
  • [45] Safety of Clinical and Non-Clinical Decision Makers in Telephone Triage: A Narrative Review
    Wheeler, Sheila Q.
    Greenberg, Mary E.
    Mahlmeister, Laura
    Wolfe, Nicole
    JOURNAL OF TELEMEDICINE AND TELECARE, 2015, 21 (06) : 305 - 322
  • [46] Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use
    Klingbeil, C
    Hsu, DH
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 1 - 3
  • [47] Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
    Smith, Scott A.
    Crowe, James E., Jr.
    MICROBIOLOGY SPECTRUM, 2015, 3 (01):
  • [48] Translational knowledge in minipigs: a way forward to reduce the use of nonhuman primates in non-clinical safety studies
    van Cruchten, S.
    TOXICOLOGY LETTERS, 2023, 384 : S3 - S3
  • [49] PRODUCTION OF MONOCLONAL-ANTIBODIES TO THEOPHYLLINE FOR CLINICAL USE
    GELTOSKY, JE
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1201 - 1201
  • [50] Viral infections associated with the clinical use of monoclonal antibodies
    Gentile, G.
    Foa, R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (12) : 1769 - 1775
12345